A phase Ia/b trial of ARX788 combined with toripalimab for HER2-low advanced breast cancer (ABC) and other HER2-expressing solid tumors

被引：0
|
作者：
Shao, Xiying
Kuang, Ming
Chen, Zhanhong
Zheng, Yabing
Li, Guangliang
Shen, Xia-Bo
Huang, Ping
Cao, Wenming
Xu, Lixia
Wang, Xiaojia
机构：
[1] Univ Chinese Acad Sci, Zhejiang Canc Hosp, Canc Hosp, Dept Breast Med Oncol, Hangzhou, Peoples R China
[2] Sun Yat Sen Univ, Affiliated Hosp 1, Ctr Hepatopancreatobiliary Surg, Guangzhou, Peoples R China
[3] Univ Chinese Acad Sci, Canc Hosp, Breast Canc Ctr, Zhejiang Canc Hosp, Hangzhou, Peoples R China
[4] Zhejiang Canc Hosp, Hangzhou, Peoples R China
[5] Univ Chinese Acad Sci, Zhejiang Canc Hosp, Canc Hosp, Hangzhou, Peoples R China
[6] Univ Chinese Acad Sci, Canc Hosp, Hangzhou, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e13159
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Phase 1 dose escalation study of ARX788, a next-generation anti-HER2 antibody drug conjugate, in heavily pretreated breast cancer patients
    Frentzas, Sophia
    Park, Haesong
    Budd, George
    Ganju, Vinod
    Shannon, Catherine
    Hurvitz, Sara
    Cuff, Katharine
    Lau, Peter
    Eek, Richard
    O'Shaughnessy, Joyce
    Boyle, Fran
    Aung, Sandra
    Hessel, Colin
    Lu, Janice
    CANCER RESEARCH, 2024, 84 (09)
  • [32] Phase I study of A166, an antibody‒drug conjugate in advanced HER2-expressing solid tumours
    Jian Zhang
    Rujiao Liu
    Shuiping Gao
    Wenhua Li
    Yang Chen
    Yanchun Meng
    Chang Liu
    Wenyue Jin
    Junyan Wu
    Ying Wang
    Yanrong Hao
    Shuli Yi
    Yan Qing
    Junyou Ge
    Xichun Hu
    npj Breast Cancer, 9
  • [33] Pharmacokinetics, Safety, and Efficacy of Trastuzumab Deruxtecan with Concomitant Ritonavir or Itraconazole in Patients with HER2-Expressing Advanced Solid Tumors
    Takahashi, Shunji
    Karayama, Masato
    Takahashi, Masato
    Watanabe, Junichiro
    Minami, Hironobu
    Yamamoto, Noboru
    Kinoshita, Ichiro
    Lin, Chia-Chi
    Im, Young-Hyuck
    Achiwa, Issei
    Kamiyama, Emi
    Okuda, Yasuyuki
    Lee, Caleb
    Bang, Yung-Jue
    CLINICAL CANCER RESEARCH, 2021, 27 (21) : 5771 - 5780
  • [34] A phase I vaccine trial of a HER-2/neu peptide incorporated into PLG microspheres in patients with advanced stage HER2-expressing cancers.
    Salazar, L. G.
    Murray, J. L.
    Disis, M. L.
    Cheever, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 118S - 118S
  • [35] Beamion Lung 1, a Phase Ia/Ib Trial of the HER2 TKI, BI 1810631 in Patients with Advanced Solid Tumors with HER2 Aberrations
    Yamamoto, N.
    Opdam, F.
    Barve, M.
    Tu, H. -Y.
    Wu, Y. -L.
    Schroeter, L.
    Sadrolhefazi, B.
    Serra, J.
    Yoh, K.
    Heymach, J.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S147 - S147
  • [36] Gemcitabine treatment enhances HER2 expression in low HER2-expressing breast cancer cells and enhances the antitumor effects of trastuzumab emtansine
    Kan, Shin
    Koido, Shigeo
    Okamoto, Masato
    Hayashi, Kazumi
    Ito, Masaki
    Kamata, Yuko
    Komita, Hideo
    Ishidao, Takefumi
    Nagasaki, Eijiro
    Homma, Sadamu
    ONCOLOGY REPORTS, 2015, 34 (01) : 504 - 510
  • [37] Preclinical study and phase 2 trial of neoadjuvant pyrotinib combined with chemotherapy in luminal/HER2-low breast cancer: PILHLE-001 study
    Gong, Chang
    Xia, Yuan
    Zhu, Yingying
    Yang, Yaping
    Lin, Qun
    Liu, Qiang
    Yang, Wenqian
    Ling, Li
    Zhong, Jiajie
    Duan, Zhuxi
    Zeng, Yunjie
    Cheng, Ziliang
    Shen, Jun
    Zeng, Yinduo
    Chow, Louis Wing Cheong
    Song, Erwei
    CELL REPORTS MEDICINE, 2024, 5 (11)
  • [38] Efficacy of a Dual-Epitope Dendritic Cell Vaccine as Part of Combined Immunotherapy for HER2-Expressing Breast Tumors
    Vincent, Benjamin G.
    File, Danielle M.
    McKinnon, Karen P.
    Moore, Dominic T.
    Frelinger, Jeffrey A.
    Collins, Edward J.
    Ibrahim, Joseph G.
    Bixby, Lisa
    Reisdorf, Shannon
    Laurie, Sonia J.
    Park, Yara A.
    Anders, Carey K.
    Collichio, Frances A.
    Muss, Hyman B.
    Carey, Lisa A.
    van Deventer, Hendrik W.
    Dees, E. Claire
    Serody, Jonathan S.
    JOURNAL OF IMMUNOLOGY, 2023, 211 (02): : 219 - 228
  • [39] Discordance of HER2-Low between Primary Tumors and Matched Distant Metastases in Breast Cancer
    Almstedt, Katrin
    Krauthauser, Lisa
    Kappenberg, Franziska
    Wagner, Daniel-Christoph
    Heimes, Anne-Sophie
    Battista, Marco J. J.
    Anic, Katharina
    Krajnak, Slavomir
    Lebrecht, Antje
    Schwab, Roxana
    Brenner, Walburgis
    Weikel, Wolfgang
    Rahnenfuehrer, Joerg
    Hengstler, Jan G. G.
    Roth, Wilfried
    Hasenburg, Annette
    Stewen, Kathrin
    Schmidt, Marcus
    CANCERS, 2023, 15 (05)
  • [40] A PHASE 1/1B STUDY OF SBT6050, A HER2-DIRECTED MONOCLONAL ANTIBODY CONJUGATED TO A TOLLLIKE RECEPTOR 8 AGONIST, IN SUBJECTS WITH ADVANCED HER2-EXPRESSING SOLID TUMORS
    Emens, Leisha
    Beeram, Muralidhar
    Hamilton, Erika
    Piha-Paul, Sarina
    Odegard, Valerie
    Hamke, Sue
    Hunder, Naomi
    Klempner, Samuel
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 : A195 - A195
12345